Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity
Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity
复制标题
DOI:
10.1161/01.atv.0000233358.87583.01
复制
发表时间:
2006-09-01
影响因子:
8.7
通讯作者:
Sunagawa, Kenji
中科院分区:
文献类型:
--
作者:
Fukuyama, Kae;Ichiki, Toshihiro;Sunagawa, Kenji
Objective - Although accumulating evidences suggest that impaired thyroid function is a risk for ischemic heart disease, the molecular mechanism of anti-atherosclerotic effects of thyroid hormone is poorly defined. We examined whether thyroid hormone affects signaling pathway of angiotensin II ( Ang II), which is critically involved in a broad aspect of cardiovascular disease process.Methods and Results - 3,3', 5- triiodo-L-thyronine (T3) did not show a significant effect on Ang II-induced activation of extracellular signal-regulated protein kinase or p38 mitogen-activated protein kinase in vascular smooth muscle cells (VSMCs), whereas T3 inhibited Ang II-induced activation of cAMP response element (CRE) binding protein ( CREB), a nuclear transcription factor involved in the vascular remodeling process. Coimmunoprecipitaion assay revealed the protein-protein interaction between thyroid hormone receptor and CREB. T3 reduced an expression level of interleukin (IL)-6 mRNA, CRE-dependent promoter activity, and protein synthesis induced by Ang II. Administration of T3 ( 100 mu g/100 g for 14 days) to rats attenuated neointimal formation after balloon injury of carotid artery with reduced CREB activation and BrdU incorporation.Conclusion - These results suggested that T3 inhibits CREB/CRE signaling pathway and suppresses cytokine expression and VSMCs proliferation, which may account for, at least in part, an anti-atherosclerotic effect of thyroid hormone.